News

Drug production is a crucial component of Indonesia’s healthcare system, with significant implications for public health, economic development, and regulatory compliance. As one of the largest pharmaceutical markets in Southeast Asia, Indonesia’s drug production sector faces a complex array of challenges and opportunities. This article examines the current state of drug production in Indonesia, key challenges, and potential strategies for improvement. Visit pafiweda.org. Overview of Drug Production in Indonesia Indonesia’s drug production sector is governed by a robust regulatory framework aimed at ensuring the safety, efficacy, and quality of pharmaceuticals. The sector includes both multinational pharmaceutical companies and local manufacturers,…